" class="no-js "lang="en-US"> Chief Medical Officer Archives - Medtech Alert
Wednesday, June 19, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

EpimAb Biotherapeutics Appoints Yonghong Zhu, M.D., Ph.D., as Chief Medical Officer

EpimAb Biotherapeutics, a clinical-stage biotechnology company specializing in the development of bispecific antibodies, today announced […]

RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors

RenovoRx, a biopharmaceutical company focused on targeted drug-delivery with an initial application in locally advanced […]

Legend Biotech Announces Appointment of Chief Medical Officer

Legend Biotech, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening […]

Rocket Pharmaceuticals Announces Leadership Expansion to Support Company on Evolution Towards Commercial Stage

Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]

BioSenic Appoints Lieven Huysse, MD, as Chief Medical Officer (CMO)

BioSenic, the company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces […]

Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer

Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today […]

CLEARA Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development

CLEARA Biotech, a preclinical-stage biotechnology company focused on developing innovative, proprietary therapies for treating different […]

Medivir Announces Pia Baumann as Chief Medical Officer (CMO)

Medivir AB, a pharmaceutical company focused on developing innovative treatments for cancer in areas of […]

Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer

Abivax SA, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the […]

Avita Care Solutions Names Dr. Christopher Hall First Chief Medical Officer

Avita Care Solutions, a national healthcare services organization committed to providing comprehensive, compassionate, and inclusive […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more